IMVT Form 144: Proposed sale of 6,000 shares

Issuer files a Form 144 reporting proposed sale and recent dispositions of Common Stock.

Rhea-AI Filing Summary

Issuer files a Form 144 reporting proposed sale and recent dispositions of Common Stock. The filing lists 6,000 shares tied to an exercise of stock options with a proposed sale date of 06/15/2026. It also reports prior 10b5-1 sales of 6,000 shares on 05/20/2026 for $192,000.

Insights

Securities Compliance Expert

Routine resale notice and exercise disclosure under Rule 144 with a prior 10b5-1 sale.

The filing records a planned sale of 6,000 shares associated with an exercise of stock options and cites a prior 10b5-1 sale of 6,000 shares on 05/20/2026 for $192,000. This is a regulatory notice of intent to sell and an exercise-related transaction.

Timing and cash‑flow treatment are stated as cash and dated 06/15/2026. Future filings (if any) would show actual settlement and change in beneficial ownership; the current record is a standard disclosure under resale rules.

Key Figures

Proposed shares to sell: 6,000 shares Prior sale quantity: 6,000 shares Proceeds from prior sale: $192,000 +1 more

4 metrics

Proposed shares to sell 6,000 shares Exercise of stock options dated 06/15/2026

Prior sale quantity 6,000 shares 10b5-1 sales on 05/20/2026

Proceeds from prior sale $192,000 10b5-1 sale on 05/20/2026

Planned sale date 06/15/2026 Date listed for exercise/sale

Key Terms

10b5-1, Exercise of Stock Options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for ATUL PANDE 1000 Park Forty Plaza"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options | Issuer"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IMVT's Form 144 report?

It reports a proposed sale of 6,000 shares tied to an exercise of stock options dated 06/15/2026. The filing also discloses prior 10b5-1 sales of 6,000 shares on 05/20/2026 for $192,000.

Who executed the prior 10b5-1 sales noted in the filing?

The filing identifies 10b5-1 sales for Atul Pande on 05/20/2026 totaling 6,000 shares and producing $192,000. The entry is a reported disposition under an established trading plan.

Are the 6,000 shares being sold part of an option exercise?

Yes. The Form 144 lists 6,000 shares under "Exercise of Stock Options" with a proposed sale method and a sale date of 06/15/2026, and indicates cash as the consideration method.

Does the filing state how much cash the issuer or seller will receive?

The filing shows prior 10b5-1 sales produced $192,000 for 6,000 shares. For the proposed 06/15/2026 exercise-and-sale, the filing lists cash as the method but does not state a dollar amount for that planned sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001643071
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMMUNOVANT, INC.
SEC File Number	001-38906
Address of Issuer	1000 Park Forty Plaza Durham NORTH CAROLINA 27713
Phone	9174103120
Name of Person for Whose Account the Securities are To Be Sold	Atul Pande
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6000	201720.00	205308917	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2026	Exercise of Stock Options	Issuer			6000	06/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ATUL PANDE 1000 Park Forty Plaza Durham NC 27713	Common	05/20/2026	6000	192000.00

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	06/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Atul Pande
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)